Biotricity (NASDAQ:BTCY) Shares Up 6.9% – What’s Next?

Biotricity, Inc. (NASDAQ:BTCY) traded up 6.9% during trading on Thursday . The stock traded as high as $0.33 and last traded at $0.31. 104,856 shares changed hands during mid-day trading, an increase of 37% from the average session volume of 76,434 shares. The stock had previously closed at $0.29.

Analysts Set New Price Targets

Separately, HC Wainwright reiterated a “neutral” rating on shares of Biotricity in a research note on Monday, November 18th.

Biotricity Stock Performance

The firm has a market cap of $8.59 million, a P/E ratio of -0.26 and a beta of 1.14. The firm has a fifty day moving average of $0.32 and a 200-day moving average of $0.46.

Institutional Trading of Biotricity

A hedge fund recently bought a new stake in Biotricity stock. AE Wealth Management LLC bought a new stake in Biotricity, Inc. (NASDAQ:BTCY) during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm bought 97,751 shares of the company’s stock, valued at approximately $88,000. AE Wealth Management LLC owned 0.45% of Biotricity at the end of the most recent reporting period. Hedge funds and other institutional investors own 3.89% of the company’s stock.

Biotricity Company Profile

Biotricity, Inc, a medical technology company, provides biometric data monitoring solutions in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses.